iCoreConnect Inc. (NASDAQ:ICCT) Sees Large Decrease in Short Interest

iCoreConnect Inc. (NASDAQ:ICCT) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 74,800 shares, a decrease of 6.8% from the August 15th total of 80,300 shares. Based on an average daily volume of 27,000 shares, the days-to-cover ratio is currently 2.8 days. Approximately 1.0% of the company’s shares are sold short.

iCoreConnect Stock Performance

Shares of NASDAQ ICCT opened at $0.43 on Thursday. The firm has a 50-day simple moving average of $0.59 and a two-hundred day simple moving average of $0.93. iCoreConnect has a 1 year low of $0.43 and a 1 year high of $4.54. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.11 and a quick ratio of 0.11.

iCoreConnect (NASDAQ:ICCT) last announced its quarterly earnings data on Friday, August 16th. The company reported ($1.10) EPS for the quarter. iCoreConnect had a negative net margin of 260.79% and a negative return on equity of 614.22%. The business had revenue of $3.09 million during the quarter.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.